oral SETD2 Inhibitor

Ph. I candidate in oncology

in-house library screening and SBDD

ACS Med. Chem. Lett.

Epizyme Inc., Cambridge, MA

EZM0414 Chemical Structure oral SETD2 Inhibitor - Epizyme Inc., Cambridge, MA

Context. EZM0414 (Epizyme, Inc.) is an oral SETD2 inhibitor being developed for hematological malignancies. Although several genetic studies have proposed that the histone methyltransferase SETD2 is a tumor suppressor…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: